FOLR1 and cancer: Notably, at concentrations of 25 nM or lower, cancer cell lines with high FRα expression (HeLa) exhibited minimal detectable reduction, whereas those with lower FRα levels (PC9) showed more pronounced depletion, suggesting that FolTAC activity may preferentially deplete FRα in contexts where its expression is limited.